These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1478285)

  • 1. Surgical quality control in an international randomized clinical trial.
    Schraffordt Koops H
    Eur J Surg Oncol; 1992 Dec; 18(6):525-9. PubMed ID: 1478285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
    Ghussen F; Krüger I; Groth W; Stützer H
    Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
    Kroon BB; Schraffordt Koops H
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
    Henneking K; Binder J; Weyers W; Schwemmle K
    Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
    Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective therapy: repeat limb perfusion for recurrent melanoma.
    Krementz ET
    J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolated regional perfusion in the treatment of malignant melanomas of the extremities.
    Schraffordt Koops H; Oldhoff J; van der Ploeg E; Vermey A; Eibergen R
    Arch Chir Neerl; 1975; 27(4):237-43. PubMed ID: 1211947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated limb perfusion in regional melanoma.
    Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
    Surg Oncol Clin N Am; 2006 Apr; 15(2):373-84. PubMed ID: 16632221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
    Hafström L; Jönsson PE
    Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
    Schraffordt Koops H; Kroon BB; Oldhoff J; Hoekstra HJ
    World J Surg; 1992; 16(2):241-5. PubMed ID: 1561805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].
    Ghussen F; Groth W; Nagel K
    Z Hautkr; 1981 Jul; 56(14):911-20. PubMed ID: 7269716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
    J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
    Binder J; Henneking K
    Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
    Huber R; Krüger I; Stützer H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
    J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of isolated limb perfusion to manage recurrent malignant melanoma.
    Ma D; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized adjuvant therapy trials in melanoma: surgical and systemic.
    Eggermont AM; Gore M
    Semin Oncol; 2007 Dec; 34(6):509-15. PubMed ID: 18083374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of melanoma.
    Wargo JA; Tanabe K
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):565-81, x. PubMed ID: 19464603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.